Metcure-T 25 Tablet ER
Marketer
Unizy Healthcare Private Limited
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Metcure-T 25 Tablet ER
CardioTen 25mg Extended Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. For consistent blood levels, take CardioTen 25mg ER with food daily at the same time, continuing as directed by your physician. Do not discontinue, even feeling well, as hypertension often lacks symptoms; stopping may worsen your condition. Lifestyle modifications – exercise, weight management, and healthy eating – further aid blood pressure control. Always follow your doctor's instructions. Potential side effects include headache, fatigue, weakness, low blood pressure, elevated potassium, occasional orthostatic hypotension (potentially with fainting), shortness of breath, nausea, vomiting, and abdominal pain. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from sitting. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be required. Inform your doctor of any kidney or liver issues before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice prior to use. Disclose all medications, particularly those for hypertension or heart conditions.
Uses of Metcure-T 25 Tablet ER
Managing elevated blood pressure
Major Benefits of Metcure-T 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metcure-T 25 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Metcure-T 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Metcure-T 25 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Metcure-T 25 Tablet ER with a meal.
How Metcure-T 25 Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Metcure-T 25 Tablet ER, offer extended-release hypertension management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Metcure-T 25 Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metcure-T 25mg tablets present a confirmed risk to fetal development and should not be taken during pregnancy. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metcure-T 25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Metcure-T 25 mg tablets can reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Metcure-T 25 tablets are considered safe for use in individuals with kidney impairment. No modification to the Metcure-T 25 tablet dosage is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Metcure-T 25 Extended-Release tablets. Dosage modification may be necessary; physician consultation is recommended.
What if you forget to take Metcure-T 25 Tablet ER :
Should you forget a dose of Metcure-T 25 Tablet ER, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metcure-T 25 Tablet ER
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Heart |